Drug Maker Agrees To Pay Record $3B Fraud Settlement

Start your day with TPM.
Sign up for the Morning Memo newsletter

The mammoth drug maker GlaxoSmithKline agreed to pay a record $3 billion fraud settlement with the Justice Department in a deal announced Monday about the way the company marketed and sold some of its most popular drugs.

The company pleaded guilty to three crimes and agreed to hand over $1 billion for how it marketed the antidepressants Wellbutrin and Paxil and for failing to report some data to the FDA for the diabetes drug Avandia.

The Justice Department said the company marketed Wellbutrin as a treatment for a variety of conditions it was never approved for, including sexual problems and drug addiction. It also said the company pushed Paxil as a treatment for people younger than 18 even though it was only approved for adults.

GlaxoSmithKline also agreed to pay another $2 billion to settle civil claims about its marketing, including kickbacks that went to doctors who prescribed the company’s drugs.

The government called it the largest healthcare fraud settlement in U.S. history. The Justice Department posted numerous documents from the case on its website.

Latest Muckraker
Comments
Masthead Masthead
Founder & Editor-in-Chief:
Executive Editor:
Managing Editor:
Associate Editor:
Editor at Large:
General Counsel:
Publisher:
Head of Product:
Director of Technology:
Associate Publisher:
Front End Developer:
Senior Designer: